C4 Therapeutics, Inc. (CCCC)
3.85
-0.25
(-6.10%)
USD |
NASDAQ |
Aug 28, 16:00
3.83
-0.02
(-0.52%)
After-Hours: 20:00
C4 Therapeutics Cash from Operations (Quarterly) : -1.574M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.574M |
| March 31, 2026 | -29.94M |
| December 31, 2025 | -22.14M |
| September 30, 2025 | -31.21M |
| June 30, 2025 | -12.06M |
| March 31, 2025 | -33.28M |
| December 31, 2024 | -17.93M |
| September 30, 2024 | -24.13M |
| June 30, 2024 | -4.974M |
| March 31, 2024 | -18.12M |
| December 31, 2023 | -24.01M |
| September 30, 2023 | -30.71M |
| June 30, 2023 | -19.00M |
| March 31, 2023 | -33.12M |
| Date | Value |
|---|---|
| December 31, 2022 | -29.13M |
| September 30, 2022 | -28.02M |
| June 30, 2022 | -22.20M |
| March 31, 2022 | -26.60M |
| December 31, 2021 | -25.67M |
| September 30, 2021 | -18.36M |
| June 30, 2021 | -18.00M |
| March 31, 2021 | -24.93M |
| December 31, 2020 | -21.54M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -16.67M |
| December 31, 2019 | -10.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -66.10M |
| Rallybio Corp. | 45.92M |
| Q32 Bio, Inc. | -3.075M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Oncolytics Biotech, Inc. | -8.066M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -14.82M |
| Cash from Financing (Quarterly) | 33.72M |
| Free Cash Flow | -85.39M |
| Free Cash Flow Per Share (Quarterly) | -0.0123 |
| Free Cash Flow to Equity (Quarterly) | -0.022M |
| Free Cash Flow to Firm (Quarterly) | -1.611M |
| Free Cash Flow Yield | -19.89% |